Medicine recalls
|
| |
| Singapore: Retail-level recall of one batch of Twynsta (telmisartan/amlodipine) 40mg/10mg Tablets due to erroneous distribution of rejected batch |
| |
Health Sciences Authority (HSA) announces that Boehringer Ingelheim Singapore Pte Ltd is recalling one batch of Twynsta (telmisartan/amlodipine) 40mg/10mg Tablets (batch number: 22E2317) to the retail level because of erroneous distribution of rejected batch due to missing of transport temperature data logger.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/product-recall/recall-of-twynsta-(telmisartan-amlodipine)-40mg-10mg-tablets
In Hong Kong, Twynsta Tab 40mg/10mg (HK-60511) is a pharmaceutical product registered by Boehringer Ingelheim (HK) Ltd. It is a prescription-only medicine. As confirmed by the company, the affected batch has not been imported into Hong Kong.
Ends/Wednesday, Sep 27, 2023
Issued at HKT 16:00
|
| |
